These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 12123423)

  • 21. [symbol: see text]Caspofungin and [symbol: see text]voriconazole for fungal infections.
    Drug Ther Bull; 2004 Jan; 42(1):5-8. PubMed ID: 14768298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of caspofungin and the echinocandins in the antifungal armamentarium.
    Morrison VA
    Curr Opin Investig Drugs; 2002 Oct; 3(10):1432-6. PubMed ID: 12431014
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Caspofungin: the first in a new class of antifungal agents.
    Kartsonis NA; Nielsen J; Douglas CM
    Drug Resist Updat; 2003 Aug; 6(4):197-218. PubMed ID: 12962685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Caspofungin.
    Chandrasekar PH; Manavathu EK
    Drugs Today (Barc); 2002 Dec; 38(12):829-46. PubMed ID: 12582472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Voriconazole: review of a broad spectrum triazole antifungal agent.
    Kofla G; Ruhnke M
    Expert Opin Pharmacother; 2005 Jun; 6(7):1215-29. PubMed ID: 15957974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Caspofungin.
    Parakh A; Dubey AP; Samanta D
    Indian Pediatr; 2008 Nov; 45(11):905-10. PubMed ID: 19029563
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Review of the safety, tolerability, and drug interactions of the new antifungal agents caspofungin and voriconazole.
    Ullmann AJ
    Curr Med Res Opin; 2003; 19(4):263-71. PubMed ID: 12841918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Caspofungin: in pediatric patients with fungal infections.
    Garnock-Jones KP; Keam SJ
    Paediatr Drugs; 2009; 11(4):259-69. PubMed ID: 19566110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retrospective study of the safety of caspofungin in immunocompromised pediatric patients.
    Franklin JA; McCormick J; Flynn PM
    Pediatr Infect Dis J; 2003 Aug; 22(8):747-9. PubMed ID: 12938676
    [No Abstract]   [Full Text] [Related]  

  • 30. The echinocandins.
    Cappelletty D; Eiselstein-McKitrick K
    Pharmacotherapy; 2007 Mar; 27(3):369-88. PubMed ID: 17316149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Caspofungin in the treatment of candidosis and aspergillosis.
    Maertens J; Boogaerts M
    Int J Infect Dis; 2003 Jun; 7(2):94-101. PubMed ID: 12839709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A prospective, multicenter study of caspofungin for the treatment of documented Candida or Aspergillus infections in pediatric patients.
    Zaoutis TE; Jafri HS; Huang LM; Locatelli F; Barzilai A; Ebell W; Steinbach WJ; Bradley J; Lieberman JM; Hsiao CC; Seibel N; Laws HJ; Gamba M; Petrecz M; Taylor AF; Strohmaier KM; Chow JW; Kartsonis NA; Ngai AL
    Pediatrics; 2009 Mar; 123(3):877-84. PubMed ID: 19255017
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy.
    Maertens J; Raad I; Petrikkos G; Boogaerts M; Selleslag D; Petersen FB; Sable CA; Kartsonis NA; Ngai A; Taylor A; Patterson TF; Denning DW; Walsh TJ;
    Clin Infect Dis; 2004 Dec; 39(11):1563-71. PubMed ID: 15578352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Caspofungin: a potential cause of reversible severe thrombocytopenia.
    Lynch J; Wong-Beringer A
    Pharmacotherapy; 2004 Oct; 24(10):1408-11. PubMed ID: 15628837
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Caspofungin after solid organ transplantation in Germany: observational study on treatment of invasive fungal infections].
    Lichtenstern C; Pratschke J; Schulz U; Schmoeckel M; Knitsch W; Kaskel P; Krobot KJ; Weigand MA; Winkler M
    Anaesthesist; 2010 Dec; 59(12):1083-90. PubMed ID: 21069271
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Caspofungin for prophylaxis and treatment of fungal infections in adolescents and adults: a meta-analysis of randomized controlled trials.
    Yuan X; Wang R; Bai CQ; Song XJ; Liu YN
    Pharmazie; 2012 Apr; 67(4):267-73. PubMed ID: 22570929
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of newer antifungal therapies in clinical practice: what do the data tell us?
    Perfect JR
    Oncology (Williston Park); 2004 Nov; 18(13 Suppl 7):15-23. PubMed ID: 15651178
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Echinocandins: the newest class of antifungals.
    Sucher AJ; Chahine EB; Balcer HE
    Ann Pharmacother; 2009 Oct; 43(10):1647-57. PubMed ID: 19724014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Echinocandins in the management of invasive fungal infections, Part 2.
    Morris MI; Villmann M
    Am J Health Syst Pharm; 2006 Oct; 63(19):1813-20. PubMed ID: 16990627
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized double-blind study of caspofungin versus amphotericin for the treatment of candidal esophagitis.
    Villanueva A; Arathoon EG; Gotuzzo E; Berman RS; DiNubile MJ; Sable CA
    Clin Infect Dis; 2001 Nov; 33(9):1529-35. PubMed ID: 11588698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.